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Background: Free radicals (FR) and other reactive oxygen species (ROS) are major sources of concern in some health 
conditions such as wounds, ulcers, inflammations, heart troubles and cancers amongst many others. These chemical 
species have been implicated as the causative agents of these and many more similar disease conditions. The cost of 
treating / managing these medical conditions has continued to take a huge toll on the socio-economic status of 
sufferers/patients. Many bio-resources such as plants are now being used to mitigate this worrisome health challenge. 
Objective: To investigate the antioxidant activity of Acalypha wilkesiana var. golden-yellow (Muell & Arg.) syn. A. 
wilkesiana var. tropical tempest.  
Methods: The leaf crude extract, butanol fraction and three isolates (W-1, W-2 and W-3 previously obtained from the 
silica-gel column chromatographic separation of the butanol fraction) were to be screened for antioxidant activities 
using the rapid free-radical scavenging activity test and absorption spectrophotometry, both employing DPPH 
reagent. 
Results: The initial free-radical scavenging activity of the plant was confirmed when the DPPH reagent-sprayed spots 
of the plant extract/fraction/isolates (W-1, W-2 and W-3) showed white color on purple background. W-1 (an ester) 
gave a marginal IC50 of 0.77 μg mL-1as vitamin A at 0.79 μg mL-1 while W-2 (a diol) and W-3 (phenol) both 
demonstrated moderate antioxidant activities of 0.58 and 0.53 μg mL-1 respectively. However, W-3 was more 
antioxidant in its action and its value compare favorably with IC50   value obtained with vitamin C (a standard 
antioxidant drug) at 0.41μg mL-1.  
Conclusion: The results of the antioxidant assays have showed that the compounds obtained from the plant 
(especially W-2 and W-3) could be considered as lead antioxidant drug templates in further in-vitro [especially 
structural activity relationship studies (SARS)] and in-vivo studies with the aim of improving on their activities. 
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1. Introduction 
Oxidation is a chemical reaction which generates energy 
to fuel different biological processes which occur in the 
human body. However, this reaction usually produces 
free radicals (FR) and other reactive oxygen species 
(ROS) which cause cellular and tissue damage and 
eventually death. These chemical species have been 
implicated as the causative agents in many degenerative 
conditions such as Alzheimer’s and Parkinson’s 
diseases, stroke, cancers, pancreatitis, laryngitis, 
asthma, hay fever, rheumatoid arthritis, wounds, 
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atherosclerosis, emphysema, lung dysfunction, 
radiation injuries, premature aging and diabetes 
amongst many others (Toda and Shirataki, 1998; 
Speroni et al, 1998; Ashcroft, 1999; Burits and Bucar, 
2000; Baxter et al, 2004; Dufeng and Arthur, 2004; 
Guyton and Hall, 2006; Piper, 2006; Nadier,  2007). 
Living organisms possess antioxidant defense and 
repair systems which offer some protection against 
oxidative damage but nevertheless are insufficient to 
prevent the damage.  
However, antioxidant supplements or foods containing 
these antioxidants could aid the human body reduce 
oxidative damage. Currently, serious research focus is 
on the search for phytochemicals in foods, spices and 
plant resources which could serve as alternative 
antioxidant drug templates with better activity, low or 
no toxicities and most especially more at cheaper costs 
than those in current clinical use. One of such plants is 
A. wilkesiana var. golden-yellow (Muell & Arg.) syn. A. 
wilkesiana var. tropical tempest which is a species and 
variety used in native medicine for the treatment of 
gastrointestinal disorders, skin diseases and more 
especially ulcers, wounds and inflammations. Before 
now, three compounds namely, 4-ethoxy-4-oxobutanoic 
acid (ethyl succinate), 2-ethoxy-5(hydroxymethyl)-
oxalane-3, 4-diol (ethyl β-riboside) and 3,4-Di-tert-butyl 
hydroxybenzene (Oladimeji et al, 2016a; Oladimeji et al, 
2016b) have been obtained from the butanol fraction of 
the plant. This present study was carried out by 
subjecting the crude extract, butanol fraction and the 
three isolated compounds to antioxidant tests with a 
view of confirming or disproving its reported uses in 
folklore medicine for the treatment/ management of 
inflammation conditions which arise out of the 
debilitating incidence of free-radicals. 
2. Materials and Methods 
2.1 Collection of plant material                                                                                                                                                                                          
The fresh leaves of A. wilkesiana var. golden-yellow 
(Muell & Arg.) were collected in the month of March, 
2015 within the University of Uyo Town Campus, Uyo, 
Akwa Ibom State, Nigeria. The plant had previously 
been identified in a study (Oladimeji et al, 2016a).  
Immediately after collection, the leaves were dried in an 
oven (Gallenkamp, England) at 40 0C for 48 h and the 
dried material was powdered on an electric mill 
(Electrothermal, England).                                                                                                                                                                                                                                                                                                                                                                                                                                    
2.2 Extraction and processing of plant material  
The powder was extracted with cold 96 % ethanol at 
room temperature (27  2 0C) for 72 h. The obtained 
filtrate was then evaporated to dryness in-vacuo on a 
rotary evaporator (R205D, Shensung BS & T, China).  A 
portion of the dried extract was dissolved in enough 
distilled water and repeatedly partitioned with butanol. 
The combined butanol fractions were bulked and 
likewise concentrated in-vacuo on a rotary evaporator. 
The extract, butanol fraction and isolates W-1, W-2 and 
W-3 previously obtained from the chromatographic 
separation of the butanol fraction (Oladimeji et al, 
2016a; Oladimeji et al, 2016b)  were kept in 
appropriately labeled amber bottles and then stored in 
a refrigerator at -4 0C prior to the antioxidant tests. 
2.3 Test for antioxidant activity 
2.3.1 Initial rapid thin-layer chromatographic assay 
The DPPH (2, 2-Diphenyl-1-picryhydrazyl hydrate) 
assay is based on the principle of reduction. The purple 
colour of the methanolic solution of DPPH is bleached 
when it accepts hydrogen or electrons from extracts or 
standard antioxidant drug. The 2, 2-Diphenyl-1-
picrylhydrazyl (DPPH) molecule is noted for its stable 
free radical nature and when mixed with a substance 
that can donate a hydrogen atom or electrons results in 
its reduced form, 1,1-Diphenyl-2-picrylhydrazine. The 
tests were done by developing the spotted samples of 
crude extract, butanol fraction and W-1, W-2 and W-3 in 
ethyl acetate: methanol (1:2) solvent mixture in 
duplicates. Ascorbic acid (Emzor Drugs, Nigeria) was 
spotted along to serve as positive control. The 
developed chromatograms were sprayed with 0.1 % 
w/v methanolic solution of DPPH reagent (Sigma-
Aldrich, Germany). The plates were irradiated with 
ultra-violet light at λm 366 nm for 15 minutes. Spots 
which appeared white against a purple background  
(Bondet et al,1997; Cuendet et al,1997; Kirby and 
Schmdt, 1997) were taken as evidence of positive tests 
indicating antioxidant activity.                                                                                                                                                                                                                                                                                       
                                                                                                                                                  
2.3.2 Spectrophotometric determination of 
antioxidant activity using DPPH reagent  
Substances which are capable of donating electrons or 
hydrogen atoms (free-radical scavengers) can convert 
the purple-coloured DPPH radical (2, 2-Diphenyl-1-
picrylhydrazyl hydrate) to its yellow-coloured non-
radical form (1, 1-Diphenyl-2-picryl hydrazine) 
(Guangrong et al, 2008; Nagalapur and Paramjyothi, 
2010). This reaction can be monitored by 
spectrophotometry. This is the most widely employed 
method of screening for antioxidant activity in plants 
(Hu and Kitts, 2000; Khaled et al, 2002; Singh et al,
2002; Nia et al, 2003; Oladimeji et al, 2007; Oladimeji 
and Akpan, 2014; Oladimeji et al, 2016a).  
Preparation of calibration curve for DPPH reagent 
DPPH (4 mg) was weighed and dissolved in methanol 
(100 mL) to produce the stock solution (0.004 % w/v). 
Serial dilutions of the stock solution were carried out to 
obtain the following concentrations; 0.0004, 0.0008, 
0.0012, 0.0016, 0.0020, 0.0024, 0.0028, 0.0032 and 
0.0036 % w/v. The absorbance of each of the sample 
was taken at λm 512 nm using the ultra-violet 
spectrophotometer (Jenway 6405, USA). This machine 
was zeroed after an absorbance had been taken with a 
solution of methanol without DPPH which served as the 
blank.   
Determination of the antioxidant activity of crude 
extract/butanol fraction/isolates 
2 mg each of the extract/fraction/isolate was dissolved 
in 50 mL of methanol. Serial dilutions were done to 
obtain the following concentrations; 0.0008 mg mL-1, 
0.0016 mg mL-1 and 0.0024 mg mL-1 using methanol. 5 
mL of each concentration was incubated with 5 mL of 
0.004 % w/v methanolic DPPH solution for optimal 
analytical accuracy. After an incubation period of 30 
minutes in the dark at room temperature (25 ± 2 0C), 
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observation was made for a change in the colour of the 
mixture from purple to yellow. The absorbance of each 
of the test samples was then taken at λm 512 nm. The 
Radical Scavenging Activity (RSA %) or Percentage 
Inhibition (PI %) of free radical DPPH was thus 
calculated: 
      RSA % (PI %) = [(Ablank – Asample)/ Ablank] ×100  
Ablank is the absorbance of the control reaction (DPPH 
solution without the test sample and Asample is the 
absorbance of DPPH incubated with the 
extract/fraction/isolates /anti-oxidant drug.  
Extract/fraction/isolate /standard antioxidant drug 
concentration providing 50 % inhibition (IC50) was 
calculated using a graph of inhibition percentage 
against the concentration of the 
extract/fraction/isolates/standard antioxidant drug 
(Lebeau et al, 2000; Leitao et al, 2002).   
DPPH assay of standard antioxidant drugs                                                                        
Standard antioxidants namely, vitamin A (Gemini Drugs, 
Nigeria), vitamin C (Greenfield Drugs, Nigeria) and 
vitamin E (Gemini, Nigeria) were used. While vitamin C 
was in a tablet dosage form, vitamins A and E were 
formulated as gelatine capsules. The estimated weight 
of the formulations containing 2 mg of the standard 
antioxidant drugs were determined by proportionality 
and then diluted. Methanol was used to dissolve vitamin 
C, while n-hexane was used to dissolve vitamins A and E 
because solubility problems encountered with these 
two vitamins. Thus, methanolic and hexane solutions of 
0.004 % w/v DPPH were used for incubation of vitamin 
C, vitamin A and E respectively for 30 minutes.  
The absorbance value of each of the drugs was taken at 
wavelength at λm 512 nm and the IC50 determined. 
3. Results and Discussion 
Phytochemistry 
The plant was identified and collected observing basic 
rules of plant collection. Also, the principles governing 
extraction and processing of extract/fraction/isolates 
were observed, thus preventing any changes to the 
chemical composition of the crude extract (Odebiyi and 
Sofowora, 1978; Odebiyi and Sofowora, 1979). Previous 
phytochemical investigations on the plant extract 
indicated the presence of alkaloids, saponins, tannins, 
terpenes and cardiac glycosides while flavonoids, 
anthraquinones and cyanogenic glycosides were absent 
extract (Oladimeji and Akpan, 2014). The butanol 
fraction which resulted from solvent-partitioning of the 
aqueous solution of the crude extract was put through 
silica-gel column chromatographic separation. This 
exercise led to the isolation of three compounds coded 
as W-1, W-2 and W-3 respectively (Figure 1). The 
identities of these compounds have been established to 
be 4-ethoxy-4-oxobutanoic acid (ethyl succinate), 2-
ethoxy-5(hydroxymethyl)-oxalane-3, 4-diol (ethyl β-
riboside) and 3, 4-Di-tert-butyl hydroxybenzene 
respectively using a combination of 1H NMR, 13C NMR, 
MS and IR spectral techniques (Oladimeji et al, 2016a; 
Oladimeji et al, 2016b). 
Rapid thin-layer chromatographic analysis for 
antioxidant activity 
The extract/fraction/isolates and ascorbic acid gave 
white spots on purple background when the 
chromatogram was sprayed DPPH reagent. The 
observation of white spots (irrespective of initial 
spotted colour) was the evidence of reduction of DPPH 
reagent (discolouration) by the by free-radical 
scavenger in the samples.  
Determination of the antioxidant activity of 
extract/fraction/isolates/antioxidant drug  
The DPPH reagent obeys the Beer-Lambert law at 
concentrations of 50-100 μΜ (Blois, 1958). The Beer-
Lambert Law is the basis of all absorption 
spectrophotometry. Therefore, a plot of absorbance 
against concentration for a cell of unit thickness (1 cm) 
should give a straight line passing through the origin. 
The reduction of the DPPH radical was determined by 
taking its absorption at a wavelength of λm 512 nm. It 
was observed that the absorbance of DPPH decreased 
as the concentration of added free radical scavenger 
extract /fraction /isolates /standard antioxidant drug) 
increased which suggested that the DPPH reagent was 
being reduced. The results of the reduction are as 
presented in Table 1.  
The Radical Scavenging Activity (RSA %) or Percentage 
Inhibition (PI %) and the IC50 values of extract and 
standard antioxidant drugs were computed as Table 2 
shows. The RSA % is an indicator of the antioxidant 
activity of extract/fraction/isolates/standard 
antioxidant drug. (Meir et al, 1995). The antioxidant 
activities demonstrated by the plant (especially 
isolates) were not surprising because different 
preparations of A. wilkesiana var. golden-yellow are used 
in ethnomedicine to treat/manage disease conditions 
such as wounds, inflammations and tumours amongst 
so many others (Dalziel, 1956; Oliver, 1959; Oliver, 
1960; Watt and Breyer-Brandwijk, 1962; Sofowora, 
2008; Evans, 2009). W-1 (an ester) gave a marginal IC50 
of 0.77 μg mL-1as vitamin A at 0.79 μg mL-1. However, 
W-2 (a diol) and W-3 (phenol) both demonstrated 
moderate antioxidant activities of 0.58 and 0.53 μg mL-1 
respectively. Though, W-3 was more antioxidant in its 
action and its value compare favourably with IC50   value 
obtained with vitamin C (a standard antioxidant drug) 
at 0.41 μg mL-1 This was not surprising because 
terpenes and more especially hydroxylated compounds 
and phenols (tannins) have shown remarkable 
antioxidant activities in previous studies. (Tsimidou and 
Boskou, 1994; Lagouri and Boskou, 1995; Yokosawa et 
al, 1997; Daniel et al, 1998; Grassmann et al, 2001; 
Alemika et al, 2004; Malaya et al, 2004; Svoboda et al, 
2006; Oladimeji et al, 2007). Expectedly, the butanol 
fraction was poorly active at 1.17 μg mL-1 most probably 
because of purity level and IC50 of the extract could not 
be regressed from its absorbance versus concentration 
curve. Furthermore, the importance of the radical 
scavenging ability of some phytochemical compounds 
have found useful applications in the extension of shelf-
life and control of deterioration of fatty foods, 
nutriceuticals and spices (Thomas and Wade, 2001; 
Braca et al, 2003; Shahidi, 2000; Liyana-Pathirana and 
Shahidi, 2006).  
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             Figure 1: Chemical structures of W-1, W-2 and W-3 
           
      Table 1: Absorbance of samples incubated with DPPH at different concentrations 
            Key:   W-1= 4-ethoxy-4-oxobutanoic acid (ethyl succinate);    
     W-2 = 2-ethoxy-5(hydroxymethyl)-oxalane-3, 4-diol (ethyl β-riboside);   
     W-3 = 3, 4-Di-tert-butyl hydroxybenzene ; 
 
               Table 2: Radical Scavenging activity (% Inhibition) of samples at different concentrations and IC50 of samples 
      (Blank absorbance of 0.004 % w/v methanolic DPPH reagent: 0.613) 
          Key:            
             W-1= 4-ethoxy-4-oxobutanoic acid (ethyl succinate);   
            W-2 = 2-ethoxy-5(hydroxymethyl)-oxalane-3, 4-diol (ethyl β-riboside);   
             W-3 = 3, 4-Di-tert-butyl hydroxybenzene ; 
             RSA % (PI %) = Radical scavenging activity (Percentage Inhibition); 
             IC50 = Concentration at which 50 % of DPPH is Scavenged or Inhibited;  
    NR = Not Regressed (Value could not be regressed from the % inhibition-concentration curve). 
  
 
Sample 
Absorbance λmax (512 nm) 
0.0008 mg mL-1 0.0016 mg  mL-1 0.0024 mg mL-1 
A .wilkesiana var. golden-yellow.  0.538 0.532 0.520 
Butanol fraction 0.324 0.322 0.276 
W-1 0.270 0.263 0.259 
W-2 0.166 0.164 0.161 
W-3 0.115 0.107 0.096 
Vitamin A 0.298 0.267 0.257 
Vitamin C 0.115 0.098 0.078 
Vitamin E 0.163 0.157 0.152 
                   Sample 
RSA % (PI %) 
IC50 (μg mL-1) 
0.0008 mg mL-1 0.0016 mg mL-1 0.0024 mg  mL-1 
A. wlkesiana  var. golden-yellow  12.23 13.21 15.17 NR 
Butanol fraction 47.14 47.47 54.97 1.17 
W-1 55.60 57.10 57.75 0.77 
W-2 72.93 73.24 73.74 0.58 
 W-3 81.24 82.54 84.40 0.53 
Vitamin A 51.39 56.44 58.07 0.79 
Vitamin C 81.57 84.01 87.28 0.41 
Vitamin E 73.41 74.39 75.20 0.60 
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4.0 Conclusion 
The results of this present study indicate that 
compounds isolated from the plant have demonstrated 
antioxidant activities which compare favourably with 
some of the standard antioxidant drugs in clinical 
practice. Also, these compounds are currently being 
further investigated (in-vitro SAR studies) in our 
laboratories with a view to improving on the 
demonstrated activities.  
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